Similar articles

• [Pseudo-crossreactivity between aspirin and tartrazine].

  Valsecchi R, Tribbia G, Rossi A, Perego GB, Cainelli T. Valsecchi R, et al. G Ital Dermatol Venereol. 1988 Apr;123(4):177-80. G Ital Dermatol Venereol. 1988. PMID: 3182007 Italian. No abstract available.
• Tartrazine: a potentially hazardous dye in Canadian drugs.

  MacCara ME. MacCara ME. Can Med Assoc J. 1982 Apr 15;126(8):910-4. Can Med Assoc J. 1982. PMID: 7074487 Free PMC article.
• Tartrazine: a yellow hazard.

  [No authors listed] [No authors listed] Drug Ther Bull. 1980 Jul 4;18(14):53-5. Drug Ther Bull. 1980. PMID: 7398537 No abstract available.
• New considerations regarding the risk assessment on Tartrazine An update toxicological assessment, intolerance reactions and maximum theoretical daily intake in France.

  Elhkim MO, Héraud F, Bemrah N, Gauchard F, Lorino T, Lambré C, Frémy JM, Poul JM. Elhkim MO, et al. Regul Toxicol Pharmacol. 2007 Apr;47(3):308-16. doi: 10.1016/j.yrtph.2006.11.004. Epub 2007 Jan 10. Regul Toxicol Pharmacol. 2007. PMID: 17218045 Review.
• Tartrazine sensitivity.

  Dipalma JR. Dipalma JR. Am Fam Physician. 1990 Nov;42(5):1347-50. Am Fam Physician. 1990. PMID: 2239641 Review.